Semaglutide for managing overweight and obesity in young people aged 12 to 17 years (terminated appraisal). NICE technology appraisal guidance 910
National Institute for Health and Care Excellence (NICE)
Record ID 32018011951
English
Details
Project Status:
Completed
URL for project:
https://www.nice.org.uk/guidance/ta910
Year Published:
2023
URL for published report:
https://www.nice.org.uk/guidance/ta910
English language abstract:
An English language summary is available
Publication Type:
Full HTA
Country:
England
MeSH Terms
- Obesity
- Anti-Obesity Agents
- Pediatric Obesity
- Child
- Adolescent
- Glucagon-Like Peptides
- Hypoglycemic Agents
- Weight Loss
Contact
Organisation Name:
National Institute for Health and Care Excellence
Contact Address:
Level 1A, City Tower, Piccadilly Plaza, Manchester, M1 4BT
Contact Name:
nice@nice.nhs.uk
Contact Email:
nice@nice.nhs.uk
Copyright:
National Institute for Health and Care Excellence (NICE)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.